Staffing shortage leaving blockbuster biologics undeveloped, says expert
A shortage of bioprocess talent drives high salaries and hinders drug development, says BioPlan Associate’s Eric Langer. As biologics increasingly dominate pipelines, biomanufacturers look to traditional pharma to plug the staffing gaps. Speaking last month at the BIOLive event at CPhI Worldwi ...
The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL), in collaboration with the BioPhorum Operations Group (BPOG), ...
The New Inspection Protocol Project (NIPP) intends to increase the speed and efficiency of sterile injectable facility inspections through the se ...
South Korea’s financial regulator has concluded Samsung BioLogics inflated its value ahead of its initial public offering (IPO) in 2016. The CD ...
The cell and gene therapy tool supplier space is ripe for consolidation says BioLife Solutions, which is evaluating several acquisition targets.
...
Recent Tweets
-
RT @Dan5tanton: NIIMBL and BPOG publish roadmaps for ADCs, vaccines and gene therapies https://t.co/rUlWeKcOhA
5 hours ago
-
RT @Dan5tanton: A shortage of #bioprocess talent drives high salaries and hinders drug development, says BioPlan Associate’s Eric L… https://t.co/QoWyeD9AeN
18 hours ago
-
Samsung BioLogics vows to prove innocence as trading suspended https://t.co/q48yotQsnA
21 hours ago
-
Korea’s financial regulator has concluded Samsung BioLogics inflated its value ahead of its IPO in 2016. The #CDMO… https://t.co/lRd5Ag9iQo
23 hours ago
Trending
Business
BioProcess International Conference and Exhibition 2018 Postevent Report: Key Insights, Highlights, and Take-Away Messages
Manufacturing
Development of a Standardized Extractables Approach for Single-Use Components: General Considerations and Practical Aspects — A Manufacturer's Perspective
Analytical
Viral Risk Mitigation: A Global Regulatory Perspective
Downstream Processing
Inactivation of Enveloped Viruses: Seeking Alternatives to a Problematic Surfactant